Granules encourage its customers to replace their conventional strategy of captive manufacture with prudent outsourcing. Our value proposition comprises of the following:
ANDA / dossier filing made easier, since we research and document on parameters like dissolution, disintegration, forced degradation, Stability and bio studies.
Putting customers at ease by filing ANDA / dossiers for finished dosages, which are repacked and marketed by the customers under their own brand name.
Relief for customers from regulatory rigors as well as manufacturing and cleaning process validation responsibilities.
The highest outsourcing value proposition at the lowest cost.
Outsourcing a significant part of the cost in manufacture of finished dosages.
Significant savings in sampling, analytical, regulatory, R&D and manufacturing resources.
The manufacture of PFIs (strategically backward integrated through the in-house manufacture of APIs) to finished dosages (tablets in bulk).
The facilitation of 'quickest-to-market with lowest cost' solutions.
A non-competing and mutually exclusive business relationship with its customers.
Delivering more than a profitable transaction for its customers : A Long-term Partnership.
Many of our customers have benefited by the value-added product development and Innovational out sourcing concepts for the pharmaceutical industry
